Abstract: The present application provides a method for preparing a medical product for covering tissue, the method comprising providing nanofibrillar cellulose, providing a bioactive molecule, and covalently bonding the bioactive molecule to the nanofibrillar cellulose. The present application also provides a medical product for covering tissue comprising a bioactive molecule covalently bound to nanofibrillar cellulose.

Abstract: The present invention concerns a process for removing metal ions from waste water, which process comprises providing plant-derived anionic nanofibrillar cellulose, carrying out a purification treatment comprising sorption of positively charged metal ions contained in the waste water to said nanofibrillar cellulose, separating used plant-derived anionic nanofibrillar cellulose from the waste water, and recovering treated waste water. The invention also concerns use of plant-derived anionic nanofibrillar cellulose for removing metal ions from waste water.

Abstract: The present disclosure provides a method for freeze-drying cells in a hydrogel comprising nanofibrillar cellulose, the method comprising providing a hydrogel comprising nanofibrillar cellulose, providing cells, combining the cells and the hydrogel comprising nanofibrillar cellulose to form a cell system, and freeze drying the cell system to obtain dried cells in a hydrogel comprising nanofibrillar cellulose. The present disclosure also provides a freeze-dried hydrogel comprising nanofibrillar cellulose and cells.

Abstract: The present application relates to a method for preparing a medical product, the method comprising providing an aqueous dispersion of nanofibrillar cellulose, providing a nonwoven fabric, immersing the nonwoven fabric in the aqueous dispersion of nanofibrillar cellulose to form a coating on the nonwoven fabric, passing the immersed nonwoven fabric through a prefined gap to define the thickness of the coating on the immersed nonwoven fabric without pressing, and dewatering the immersed nonwoven fabric, to obtain the medical product. The present application also relates to a medical product comprising a supporting layer and an absorbent layer, wherein the supporting layer comprises a nonwoven fabric, and the absorbent layer comprises unpressed nanofibrillar cellulose having an average fibril diameter of 200 nm or less, wherein the absorbent layer is coating the supporting layer.

Abstract: The present application provides a method for preparing nanofibrillar cellulose product, the method comprising providing nanofibrillar cellulose, providing multivalent cations, contacting the nanofibrillar cellulose with the multivalent cations, and allowing reacting for a period of time to obtain cross-linked nanofibrillar cellulose product. The present application also provides a nanofibrillar cellulose product comprising nanofibrillar cellulose and multivalent cations, wherein the nanofibrillar cellulose is crosslinked by the multivalent cations.

Abstract: An injectable pharmaceutical formulation includes nanofibrillar cellulose hydrogel wherein the content of nanofibrillar cellulose in the pharmaceutical formulation is the range of 1-8% (w/w), and pharmaceutical compound. The injectable pharmaceutical formulation can provide a sustained release of a pharmaceutical compound in a subject. Use of nanofibrillar cellulose for preparing the injectable pharmaceutical formulation is also disclosed.

Abstract: The present application relates to a method for preparing a pharmaceutical composition, the method comprising providing pharmaceutical compound having a solubility in water of 1 mg/ml or less at 25° C. in a solvent enabling solubilizing the pharmaceutical compound at least partly into the solvent, providing an aqueous dispersion of nanostructured cellulose, and combining the pharmaceutical compound with the aqueous dispersion of nanostructured cellulose in an anti-solvent process to provide nanosized pharmaceutical particles having an average diameter of 50 nm or less, to provide a pharmaceutical composition. The present application also provides pharmaceutical composition, and use of the pharmaceutical composition.

Abstract: A medical hydrogel includes nanofibrillar cellulose, wherein the content of nanofibrillar cellulose in the hydrogel is in the range of 1-3.5% (w/w), and the nanofibrillar cellulose includes anionic nanofibrillar cellulose having an average fibril diameter of 200 nm or less. The medical hydrogel can be used for inducing vascularization in wounds and/or for treating deep wounds of dermis and/or below tissue.

Abstract: A cell culture plate includes one or more cell culture well(s) including at least one barrier for dividing the well into at least two compartments, wherein the barrier includes nanofibrillar cellulose hydrogel, and a method for the preparation thereof. A method for detecting a substance is also disclosed.

Abstract: A process for producing a nanofibrillar cellulose hydrogel comprises obtaining bleached cellulose pulp fibers and providing an aqueous suspension thereof; and subjecting the cellulose pulp fibers in the aqueous suspension to at least 2 cycles of high pressure mechanical disintegration to obtain a nanofibrillar cellulose hydrogel and thereby reducing the number of viable microorganisms present in the suspension by a factor of at least 102; wherein all steps of the process after obtaining the bleached cellulose pulp fibers are performed under conditions of ISO 8 of ISO 14644-1 cleanroom standards or stricter. A nanofibrillar cellulose hydrogel, a system for producing the same and the use of a disintegrating apparatus are also disclosed.

Abstract: In a method for producing nanofibrillar cellulose, cellulose based fiber material in dispersion is processed for separating fibrils. The method includes a first step where the fiber material is supplied to a disperser, where it flows through several counter-rotating rotors in such a way that the material is repeatedly subjected to shear and impact forces by the effect of the different counter-rotating rotors, and a second step, where the fiber material obtained from the first step is supplied to a homogenizer, where it is subjected to homogenization by the effect of pressure.

Abstract: A method for catalytic oxidation of cellulose using a heterocyclic nitroxyl radical as catalyst, main oxidant acting as oxygen source, and an activator of the heterocyclic nitroxyl radical, comprises—a preliminary activation step of the heterocyclic nitroxyl radical with hypochlorite to activated catalyst, and after the preliminary activation step, a cellulose oxidation step using the activated catalyst and hypochlorite as the main oxidant to oxidize cellulose. In the cellulose oxidation step, fibrous starting material is subjected to the oxidation to oxidize the cellulose, whereafter the oxidized fibrous raw material is disintegrated to nanofibrillar cellulose (NFC).

Abstract: In a method for producing nanofibrillar cellulose, cellulose based fibre material, in which internal bonds in cellulose fibres have been weakened by preliminary modification of cellulose, is subjected to disintegration treatment in form of pulp comprising fibres and liquid. The fibre material is supplied at a consistency higher than 10 wt-%, preferably at least 15 wt-%, to a disintegration treatment where fibrils are detached from the fibre material by joint effect of repeated impacts to the fibre material by fast moving successive elements and the weakened internal bonds of the cellulose fibres. The nanofibrillar cellulose is withdrawn from the disintegration treatment at dry matter which is equal or higher than the consistency of the fibre material. In the disintegration treatment, the fibre material is supplied through several counter-rotating rotors (R1, R2, R3 . . .

Abstract: In a method for producing nanofibrillar cellulose, cellulose based fibre material, in which internal bonds in cellulose fibres have been weakened by preliminary modification of cellulose, is subjected to disintegration treatment in form of pulp comprising fibres and liquid. The fibre material is supplied at a consistency higher than 10 wt-%, preferably at least 15 wt-%, to a disintegration treatment where fibrils are detached from the fibre material by joint effect of repeated impacts to the fibre material by fast moving successive elements and the weakened internal bonds of the cellulose fibres. The nanofibrillar cellulose is withdrawn from the disintegration treatment at dry matter which is equal or higher than the consistency of the fibre material. In the disintegration treatment, the fibre material is supplied through several counter-rotating rotors (R1, R2, R3 . . .

Abstract: The present disclosure provides a cell system comprising eukaryotic cells in a hydrogel comprising nanofibrillar cellulose in cell storage medium at a temperature in the range of 0-25° C. The present disclosure also provides a method for storing eukaryotic cells, the method comprising providing eukaryotic cells, providing nanofibrillar cellulose, combining the cells and the nanofibrillar cellulose to form the cell system, and storing the cell system at a temperature in the range of 0-25° C.

Abstract: The present invention relates to nanofibrillar cellulose. Furthermore, the invention relates to a method for the manufacture of nanofibrillar cellulose, and to a nanofibrillar cellulose obtainable by said method. The invention also relates to uses of the nanofibrillar cellulose.

Abstract: The present invention is related to methods and materials for culturing expanding cells in a three-dimensional culture. The material comprises plant-derived anionic nanofibrillar cellulose, wherein the anionic nanofibrillar cellulose is in a form of hydrogel. The invention also provides methods for producing materials and compositions comprising plant-derived anionic nanofibrillar cellulose.

Abstract: The present invention provides a method for producing fibrillated cellulose, the method comprising providing pulp, treating said pulp at a consistency of at least 10% with a cellulase, and fibrillating said pretreated pulp to obtain fibrillated cellulose. The present invention also provides a nanofibrillar cellulose product.

Abstract: Cellulose is oxidized catalytically using a heterocyclic nitroxyl radical as catalyst, main oxidant acting as oxygen source, and an activator of the heterocyclic nitroxyl radical. The oxidation is performed in a reaction medium which is at medium consistency of cellulosic pulp, which is above 6%, more preferably equal to or higher than 8%, and most preferably in the range of 8-12%. The reaction medium is mixed in a reactor through circulation of the reaction medium back to the reactor.

Abstract: A composition or matrix comprising a bacteriophage and nanofibrillar cellulose or a derivative thereof in a wet or dry state is disclosed.